Market Cap (In INR)
2.06 Billion
Revenue (In INR)
1.97 Billion
Net Income (In INR)
1.39 Million
Avg. Volume
6370.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 80.0-335.0
- PE
- -
- EPS
- -
- Beta Value
- 0.8745775
- ISIN
- INE334C01029
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Sirisha Kakarlapudi
- Employee Count
- -
- Website
- http://www.everestorganicsltd.com
- Ipo Date
- Details
- Everest Organics Ltd. is a pharmaceutical company, which engages in the manufacture of bulk drugs. The firm's products include Omeprazole, Ciprofloxacin, Dichloroflurobenzene and Benzimadizole It also manufactures and exports active pharmaceutical ingredients and its intermediates in India; as well as supplies its products to formulation companies worldwide. The company was founded on February 19, 1993 and is headquartered in Hyderabad, India.
More Stocks
-
2484Demae-Can Co.,Ltd
2484
-
KCI
-
BFFL
-
NATIONSTDNational Standard (India) Limited
NATIONSTD
-
AZNAstraZeneca PLC
AZN
-
229000Gencurix Inc.
229000
-
300664
-
2149BaTelab Co Ltd
2149